Kaneka Corporation has reached an agreement with FUJIFILM Corporation to supply drug substances for anti-influenza drug, Avigan® Tablet for the novel coronavirus disease. While COVID-19 continues to spread, the Japanese government has decided to increase its stockpiles of Avigan® Tablet, which is expected to be effective against COVID-19, for up to 2 million people, and FUJIFILM Corporation has expanded its production system and started increasing its production of Avigan® Tablet.